AU698662B2 - Pentose fermentation by recombinant zymomonas - Google Patents
Pentose fermentation by recombinant zymomonas Download PDFInfo
- Publication number
- AU698662B2 AU698662B2 AU50582/96A AU5058296A AU698662B2 AU 698662 B2 AU698662 B2 AU 698662B2 AU 50582/96 A AU50582/96 A AU 50582/96A AU 5058296 A AU5058296 A AU 5058296A AU 698662 B2 AU698662 B2 AU 698662B2
- Authority
- AU
- Australia
- Prior art keywords
- genes
- microorganism
- ethanol
- arabinose
- xylose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000855 fermentation Methods 0.000 title claims description 62
- 230000004151 fermentation Effects 0.000 title claims description 62
- 150000002972 pentoses Chemical class 0.000 title claims description 36
- 241000588901 Zymomonas Species 0.000 title description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 315
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 173
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 166
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 157
- 108090000623 proteins and genes Proteins 0.000 claims description 138
- 244000005700 microbiome Species 0.000 claims description 97
- 239000013612 plasmid Substances 0.000 claims description 78
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 76
- 108020004530 Transaldolase Proteins 0.000 claims description 58
- 241000588902 Zymomonas mobilis Species 0.000 claims description 58
- 108010043652 Transketolase Proteins 0.000 claims description 57
- 235000000346 sugar Nutrition 0.000 claims description 55
- 102100028601 Transaldolase Human genes 0.000 claims description 49
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 44
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 42
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 42
- 239000001913 cellulose Substances 0.000 claims description 39
- 229920002678 cellulose Polymers 0.000 claims description 39
- 239000008103 glucose Substances 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 32
- 108700040099 Xylose isomerases Proteins 0.000 claims description 31
- 102000014701 Transketolase Human genes 0.000 claims description 30
- 108010018080 L-arabinose isomerase Proteins 0.000 claims description 28
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 28
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 28
- 108020002667 ribulokinase Proteins 0.000 claims description 26
- 108090000416 L-ribulose-5-phosphate 4-epimerases Proteins 0.000 claims description 25
- 241000588724 Escherichia coli Species 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 22
- 108091022915 xylulokinase Proteins 0.000 claims description 22
- 239000013598 vector Substances 0.000 claims description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 20
- 150000008163 sugars Chemical class 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 18
- 229910052799 carbon Inorganic materials 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 229940088598 enzyme Drugs 0.000 claims description 17
- 108010059892 Cellulase Proteins 0.000 claims description 14
- 102100029089 Xylulose kinase Human genes 0.000 claims description 14
- 229920002488 Hemicellulose Polymers 0.000 claims description 8
- 241000588748 Klebsiella Species 0.000 claims description 7
- 241000589634 Xanthomonas Species 0.000 claims description 7
- 241000589220 Acetobacter Species 0.000 claims description 6
- 241000589158 Agrobacterium Species 0.000 claims description 6
- 241000589180 Rhizobium Species 0.000 claims description 6
- 241000191025 Rhodobacter Species 0.000 claims description 6
- 241000607142 Salmonella Species 0.000 claims description 6
- 241000589565 Flavobacterium Species 0.000 claims description 5
- 241000589236 Gluconobacter Species 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 2
- 238000011160 research Methods 0.000 claims description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 claims 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 claims 1
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 89
- 239000012634 fragment Substances 0.000 description 63
- 235000010980 cellulose Nutrition 0.000 description 37
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 31
- 239000000203 mixture Substances 0.000 description 30
- 108091028043 Nucleic acid sequence Proteins 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 24
- 238000003752 polymerase chain reaction Methods 0.000 description 23
- 108091008146 restriction endonucleases Proteins 0.000 description 23
- 239000002609 medium Substances 0.000 description 21
- -1 pentose sugars Chemical class 0.000 description 20
- 108020004707 nucleic acids Proteins 0.000 description 19
- 102000039446 nucleic acids Human genes 0.000 description 19
- 150000007523 nucleic acids Chemical class 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 230000000692 anti-sense effect Effects 0.000 description 18
- 239000002585 base Substances 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 230000037353 metabolic pathway Effects 0.000 description 15
- 230000004108 pentose phosphate pathway Effects 0.000 description 15
- 239000004098 Tetracycline Substances 0.000 description 14
- 230000004927 fusion Effects 0.000 description 14
- 229960002180 tetracycline Drugs 0.000 description 14
- 229930101283 tetracycline Natural products 0.000 description 14
- 235000019364 tetracycline Nutrition 0.000 description 14
- 150000003522 tetracyclines Chemical class 0.000 description 14
- 101150097746 araB gene Proteins 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 230000012010 growth Effects 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 238000000246 agarose gel electrophoresis Methods 0.000 description 11
- 229940041514 candida albicans extract Drugs 0.000 description 10
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000037361 pathway Effects 0.000 description 10
- 239000012138 yeast extract Substances 0.000 description 10
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 101150024271 TKT gene Proteins 0.000 description 8
- 101150035354 araA gene Proteins 0.000 description 8
- 101150017736 araD gene Proteins 0.000 description 8
- 230000000813 microbial effect Effects 0.000 description 8
- 230000004127 xylose metabolism Effects 0.000 description 8
- 238000013019 agitation Methods 0.000 description 7
- 229940106157 cellulase Drugs 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000013605 shuttle vector Substances 0.000 description 6
- 108090000769 Isomerases Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 230000002414 glycolytic effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 102000004195 Isomerases Human genes 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 4
- 102100033055 Transketolase Human genes 0.000 description 4
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 101150014795 tktA gene Proteins 0.000 description 4
- 101150110790 xylB gene Proteins 0.000 description 4
- 108020005029 5' Flanking Region Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- 241001522878 Escherichia coli B Species 0.000 description 3
- 241001131785 Escherichia coli HB101 Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 230000006652 catabolic pathway Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 150000002402 hexoses Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- AUTALUGDOGWPQH-QCZDSKPDSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal (2R,3S,4S)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O AUTALUGDOGWPQH-QCZDSKPDSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ZAQJHHRNXZUBTE-UCORVYFPSA-N L-ribulose Chemical compound OC[C@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-UCORVYFPSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 101150073818 gap gene Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- CDVZCUKHEYPEQS-SNQKNWKTSA-N (2r,3s,4r)-2,3,4,5-tetrahydroxypentanal;(2r,3s,4s)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@H](O)[C@@H](O)C=O CDVZCUKHEYPEQS-SNQKNWKTSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- FNZLKVNUWIIPSJ-RFZPGFLSSA-N D-xylulose 5-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-RFZPGFLSSA-N 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 101900289151 Escherichia coli Xylose isomerase Proteins 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101100175482 Glycine max CG-3 gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091081548 Palindromic sequence Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 101150107963 eno gene Proteins 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- QCOXCILKVHKOGO-UHFFFAOYSA-N n-(2-nitramidoethyl)nitramide Chemical compound [O-][N+](=O)NCCN[N+]([O-])=O QCOXCILKVHKOGO-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000020038 palm wine Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019989 pulque Nutrition 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
AUSTRALIA
Patents Act COMPLETE SPECIFICATION
(ORIGINAL)
Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority Related Art: *t .s Name of Applicant: 0 Midwest Research Institute Actual Inventor(s): a.
Stephen K. Picataggio Min Zhang Christina K. Eddy Kristine A. Deanda Sa a. Address for Service: PHILLIPS ORMONDE FITZPATRICK Patent and Trade Mark Attorneys 367 Collins Street Melbourne 3000 AUSTRALIA Invention Title: PENTOSE FERMENTATION BY RECOMBINANT ZYMOMONAS Our Ref 448013 POF Code: 266648/218839 The following statement is a full description of this invention, including the best method of performing it known to applicant(s): i 1- a t 1A CONTRACTUAL ORIGIN OF THE INVENTION FIELD OF THE INVENTION This invention relates to recombinant Zymomonas mobilis strains, metabolizing xylose and arabinose and bearing xylose and arabinose utilisation and pentose phosphate pathway genes, useful for the fermentation of the xylose and arabinose components in cellulosic biomass to ethanol. This invention also relates to the process of using these strains for the rapid and efficient fermentation of the xylose and arabinose components in cellulosic biomass to ethanol.
C a 0o a o S a .e 5055S5 a 5.5.55
S
BACKGROUND OF THE INVENTION Cellulosic biomass is a favorable feedstock for fuel ethanol production because it is both readily available and less expensive than either corn or sugarcane. However, substantial hurdles must be overcome before a typical cellulosic feedstock can be utilized effectively as a substrate for the fermentative production of ethanol. The typical feedstock is comprised of approximately 35-45% cellulose, 30-40% hemicellulose, 15% lignin and of other components. The cellulose fraction is comprised of polymers of the hexose sugar, glucose. The hemicellulose fraction is comprised mostly of pentose sugars, including xylose and arabinose.
Whereas microorganisms are known that can efficiently ferment the glucose component in cellulose, conversion of the xylose and arabinose in the hemicellulose fraction to ethanol has been difficult and this remains to be one of the economic 9* bottlenecks in a biomass to ethanol conversion scheme. The rapid and efficient utilization 8 8 of the xylose and arabinose components in cellulosic biomass is desirable in the development of a commercial process.
Zymomronas mobilis is a bacterium that has been utilized as a natural fermentative agent in the production of alcoholic beverages, such as pulque and palm wines produced from plant saps. Comparative perfo-mance trials have suggested that Zymomonas may become an important industrial ethancl-producing microorganism because of its 5-10% higher yield and up to 5-fold higher productivity compared to traditional yeast fermentations. Because of its potential value, several processes based on the use of -2i- Zymomonas for the production of industrial ethanol from glucose-based feedstocks have been disclosed in US Patent Nos. 4,731,329, 4,812,410, 4,816,399, and 4,876,196.
While Zymomonas may become an important fuel ethanol-producing microorganism from glucose-based feedstocks, its substrate utilization range is restricted to fermentation of glucose, sucrose and fructose and, is not naturally suited for fermentation of the pentose component in cellulosic feedstocks. Zymomonas contains the Entner-Douderoff pathway that allows it to ferment glucose very efficiently to ethanol as the sole fermentation product. However, Zymomonas is naturally unable to ferment the pentose sugars in cellulosic biomass because it lacks the essential pentose assimilation and metabolism pathways. Thus, an opportunity exists to genetically engineer this organism for the fermentation of pentose sugars, such as xylose and arabinose to ethanol.
Genetic engineering attempts have been made to enhance ethanol production by e fermentation by transferring genes from one species to another. For example, see U.S.
Patents 5,000,000 and 5,028,539. Gene cloning and expression of various enzymes including enzymes for creating a new metabolic pathway are also known. For example see U.S. Patents 5,272,073, 5,041,378, 5,168,056 and 5,266,475. However, none of these Sdiscoveries has successfully broadened the fermentable substrate range of a microorganism which could not previously ferment pentose sugars to ethanol.
0 'Previous attempts to introduce a pentose catabolic pathway from either Xanthomonas or Klebsiella into Zymomonas have been unsuccessful and the recombinant strains were incapable of growth on xylose as the sole carbon source (Feldmann et al., 1992. Appl. Microbiol.Biotechnol. 38:354-361; Liu et al., 1988. J. Biotechnol. 7: 61-77).
-3- SUMMARY OF THE INVENTION The present invention successfully introduces a catabolic pathway for fermentation of pentose sugars, such as xylose or arabinose, into a microorganism, such as Zymomonas, which previously did not have the ability to ferment pentose sugars into ethanol. For the first time, such microorganisms are capable of growing on xylose or arabinose as a sole carbon source and fermenting either of these pentoses directly to ethanol. One embodiment introduces the genes encoding xylose isomerase and xylolukinase, xylose can be converted to xylulose-5-P. Another embodiment introduces the genes encoding L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4-epimerase, which allow the conversion of L-arabinose to D-xylulose-5-P. Then, by introducing two more genes encoding enzymes in the pentose phosphate pathway, transaldolase and transketolase, xylulose-5-P can be further converted to the key intermediates that couple *pentose metabolism to the glycolytic Entner-Douderoff pathway, and consequently, permit ,i the microorganism to metabolize pentose to ethanol. Any pentose sugar, notjust arabinose and xylose, which can be converted to xylulose-5-P can be coupled to the glycolytic Entner-Douderoff pathway, and consequently to ethanol production, by the introducti6n of these two genes which encode transaldolase and transketolase.
.Accordingly, another embodiment of the present invention provides a process for Sfermenting any pentose sugar which can be converted to xylulose-5-P to ethanol.
One aspect of the present invention provides compositions of Zymomonas mobilis containing the genes encoding L-arabinose isomerase, L-ribulokinase, ,ribulose 4-epimerase, transaldolase and transketolase cloned under the control of one -4-
T
-oor more Z. mobilis promoters such that said genes are coordinately expressed in said cells of Z. mobilis and confer upon said cells the ability to grow on and ferment arabinose directly to ethanol. In particular, compositions ofZ. mobilis are provided which contain the L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4-epimerase genes from Escherichia coli cloned precisely under the control of the Z. mobilis glyceraldehyde- 3-phosphate dehydrogenase (GAP) promoter and the transaldolase and transketolase genes from Escherichia coli cloned precisely under the control of the Z. mobilis enolase (ENO) promoter, such that all five said genes are contained on a single plasmid vector and are coordinately expressed in said cells of Z. mobilis, conferring upon said cells the ability to grow on and ferment arabinosedirectly to ethanol.
Another aspect of the present invention provides a process for producing ethanol from arabinose, or cellulosic feedstocks containing arabinose, by culturing the above o *o mentioned genetically-engineered strains of Z. mobilis in a culture medium containing 6 0 0 arabinose as a carbon source and along with an additional nitrogen source.
A further aspect of the present invention provides compositions of Zymomonas mobilis containing the genes encoding xylose isomerase, xylulokinase, transaldolase and transketolase which are under the control of one or more promoters recognized by Z.
mobilis, such that these genes are expressed in Z. mobilis. The genes confer upon Zymomonas the ability to grow on and ferment xylose directly to ethanol upon these cells.
In particular, compositions of Z. mobilis are provided which contain the xylose isomerase and xylulokinase genes from Escherichia coli which are cloned precisely under the control of the Z. mobilis glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter.
The transaldolase and transketolase genes from Escherichia coli which are cloned precisely under the control of the Z. mobilis enolase (ENO) promoter, are also provided to Z. mobilis. All four of these genes are expressed in the cells of Z. mobilis conferring upon these cells the ability to grow on and ferment xylose directly to ethanol. The cloned genes may be provided on any number of vectors but preferably are contained on a single plasmid vector. More preferably, the genes are integrated into the host genome.
Another aspect of the present invention is cultures of microorganisms with the above described abilities. The cultures may be biologically pure, mixed together, or mixed with other strains or different organisms to aid in the metabolism of the substrates or a mixture of substrates into ethanol. A related aspect of the present invention is the culture broth per se which may tolerate a small amount of contamination.
Yet another aspect of the present invention is a process for producing ethanol from t f t a pentose sugar, such as xylose or arabinose, mixtures thereof, or cellulosic feedstocks containing hemicellulose, by culturing the above mentioned genetically-engineered ,r 1 microorganisms in a culture medium containing the pentose sugars. An additional aspect of the present invention is the modification of the catabolic pathway of a microorganism, 6046 such as Zymomonas, which previously did not have the ability to ferment pentose sugars to ethanol. Such microorganisms are capable of growing on arabinose or xylose as a sole o S carbon source and fermenting arabinose or xylose directly to ethanol. By introducing the genes for converting arabinose into ethanol, a microorganism without arabinose fermentation ability may be converted into a microorganism capable of fermenting arabinose into ethanol. Similarly, by introducing the genes for converting xylose into ethanol, a microorganism without xylose fermentation ability may be converted into a microorganism capable of fermenting xylose into ethanol.
The introduction of the genes for L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4-epimerase in addition to transaldolase and transketolase allow a microbe, such as Zymomonas, to metabolise arabinose to ethanol. The introduction of the genes for xylose isomerase and xylolukinase, in addition to transaldolase and transketolase allow a microbe, such as Zymomonas, to metabolise xylose to ethanol.
Accordingly, the present invention provides the microorganism Zymomonas mobilis containing exogenous genes encoding L-arabinose isomerase, L-ribulokinase, L-ribulose-5-phosphate-4-epimerase, transaldolase and transketolase which is capable of growing on arabinose as a sole carbon source and fermenting said arabinose to ethanol, wherein said microorganism without said genes is incapable of fermenting said arabinose to ethanol.
,i 15 The present invention also provides a vector for the transformation of Zymomonas mobilis comprising genes encoding L-arabinose isomerase, Lribulokinase, L-ribulose 5-phosphate 4-epimerase, transaldolase and transketolase, and at least one promoter selected from the group consisting of Z. mobilis glyceraldehyde-3-phosphate dehydrogenase and Z.mobilis enolase 20 recognised by Zymomonas mobilis which regulates the expression of the genes.
The present invention also provides a process for producing ethanol comprising: providing a feedstock containing arabinose, adding the microorganism Zymomonas mobilis to the feedstock, said microorganism containing exogenous genes that encode L-arabinose isomerase, L-ribulokinase and Lribulose-5-phosphate-4-epimerase, transaldolase and transketolase which import arabinose to ethanol fermentation capability and wherein said microorganism without said genes is incapable of fermenting said arabinose to ethanol allowing the microorganism to ferment the arabinose in the feedstock to ST ethanol, and separating the ethanol.
C:\WINWO RD<FIONAWPJaNODELETEZ 5B200C of- 7a a..
an o a os a a an The present invention also provides a process for producing ethanol comprising, providing a mixed sugar feedstock consisting essentially of at least two sugars selected from the group consisting of glucose, fructose, sucrose, xylose and arabinose adding the m;croorganism Zymomonas mobilis containing exogenous genes to the feedstock, allowing fermentation to ethanol from sugar contained in the feedstock to occur, and separating the ethanol, wherein the microorganism is Zymomonas mobilis containing exogenous genes from a microorganism selected from the group consisting E. coli, Xanthomonas, Klebsiella, Rhodobacter, Flavobacteriur, Acetobacter, Gluconobacter, Rhizobium, Agrobacterium, Salmonella and Pseudomonads, which encode L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4epimerase, transaldolase and transketolase, and/or Zymomonas mobilis containing exogenous genes from a microorganism selected from the group consisting E. coli, Xanthomonas, Klebsiella, Rhodobacter, 15 Flavobacterium, Acetobacter, Gluconobacter, Rhizobium, Agrobacterium, Salmonella and Pseudomonads, which encode xylose isomerase and xylolukinase, transaldolase and transketolase, wherein the microorganism is capable of growing on xylose as a sole carbon source and fermenting said xylose to ethanol at about 88% of theoretical yield.
20 BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows a schematic of a process for producing the recombinant plasmid Figure 2 shows the comparative yield of ethanol using a control Zymomonas mobilis and the present recombinant strain containing pZB5 when grown on glucose, xylose or a mixture of the two sugars of sugars as the carbon source.
Figure 3 shows a schematic of a process for producing the recombinant plasmid, pZB206.
Figure 4 shows the comparative yield of ethanol using a control Zymomonas mobilis and the present recombinant strain containing pZB206 when grown on glucose, arabinose or a mixture of the two sugars as the carbon source.
Figure 5 shows the cofermentation of a mixture of xylose and glucose by the microorganism of the present invention.
I'
~z~o~sC:'.I~kMRDTINAJCNNODELETE'ZO~a2.DOC ,1 i :i Figure 6 shows the cofermentation of a mixture of xylose, glucose and cellulose by cellulase and the microorganism of the present invention.
Figure 7 shows the cofermentation of a mixture of xylose and cellulose by cellulase and the microorganism of the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The invention is the development of recombinant Zymomonas and other microbial strains with an expanded substrate utilization range and which are capable of growth on and/or efficient ethanol production from xylose, arabinose or other pentose sugars, alone or in combination, as the sole carbon source.
The microorganisms used to prepare the present invention are those which are capable of being genetically altered to produce the necessary enzymes to form a metabolic pathway for catabolizing pentose sugars, particularly xylose and arabinose. The microorganism may naturally have some enzymes in the pathway but is not able to ferment 1 "t I xylose or arabinose into ethanol until it has been genetically altered.
The manner of genetic alteration may use any combination of known genetic engineering techniques such as mutation and addition of foreign DNA, provided that the microorganism is able to ferment a pentose sugar to ethanol after treatment. Foreign DNA may be introduced into the microorganism by any conventional technique such as conjugation, transformation, transduction or electroporation.
Many microorganisms which are capable of fermenting sugars to ethanol lack at least one of the genes for the enzymes which make up a metabolic pathway for converting -8- *s~ xylose, arabinose and other pentose sugars into ethanol. Exogenous genes may be added to complete a metabolic pathway. One need not add genes necessary for every step if the host microorganism already produces an enzyme in the pathway. The number of genes to be added will depend on the starting microorganism. In the situation of imparting xylose fermentation capability to naturally occurring Zymomonas mobilis, four genes are necessary to produce enzymes to enable the pathway for metabolizing xylose to an intermediate which is further metabolized to ethanol using the glycolytic Entner-Douderoff pathway. In the situation of imparting arabinose fermentation capability to naturally occurring Zymomonas mobilis, five genes are necessary to produce enzymes to enable the pathway for metabolizing arabinose to an intermediate which is further metabolized to ethanol using the glycolytic Entner-Douderoff pathway.
The indigenous Zymomonas genes may be altered by any known genetic manipulation technique to provide a protein with the necessary enzyme act ity to produce the desired metabolic pathway. The altered genes may complement one or more of the introduced genes from another host to complete the metabolic pathway. This procedure may be advantageous by reducing the number of genes one needs to add to the host cell.
For example, Zymomonas's native transketolase may be used to substitute for a foreign transketolase gene, such as the one disclosed from E. coli.
Sufficient genes may be added so that the recipient microorganism may ferment xylose, arabinose or other pentose sugars as the sole carbon source. The microorganism may or may not be able to grow and multiply using xylose, arabinose, or combinations of 9, *9 *4 9 9., 9 9 .99
S
9S9 9 i "l"l l~ both xylose and arabinose, as the sole carbon surce, but may be capable of fermenting xylose, arabinose, or combinations of both xylose and arabinose, to ethanol.
A gene may be added to a cell by way of a vector. The vector may be in the form of a plasmid, cosmid or virus which is compatible to the cell's DNA and any resident plasmids. Generally, vectors either integrate into the recipient microorganism's DNA or the vector has an origin of replication to stably maintain the vector throughout many microbial generations. The origin of replication may code for replication under a wide range of stringency conditions.
To express the gene(s), a structural gene is generally placed downstream from a promotor region on the DNA. The promotor must be recognized by the recipient microorganism. In addition to the promotor, one may include regulatory sequences to increase or control expression. Expression may be controlled by an inducer or a repressor so that the recipient microorganism expresses the gene(s) only when desired.
In a preferred embodiment of the invention, xylose, arabinose or other pentose sugar metabolic pathway genes are obtained from pentose metabolizing microorganisms and added to Zymomonas which does not otherwise ferment pentose sugars to ethanol.
Especially preferred is Zymomonas mobilis, which historically has been used for fermenting liquids containing sugar, such as plant sap for example, into alcoholic beverages. Certain strains of Zymomonas are tolerant of up to 1.5% sodium chloride and other mutants are tolerant to acetic acid, other microbial inhibitors, high temperatures Sand/or high ethanol concentrations. The selection of host strain will depend on the substrate being used.
I1 6 1 t In another embodiment of the invention, the source for the genes encoding pentose metabolism enzymes is selected from the group consisting of: Xanthomonas, Klebsiella, E. coli, Rhodobacter, Flavobacterium, Acetobacter, Gluconobacter, Rhizobium, Agrobacterium, Salmonella, Pseudomonads and Zymomonas. In general the source of the genes for pentose sugar metabolism is any Gram-negative bacterium capable of utilizing pentose sugars for growth. A preferred organism for the source of genes is E.
coli. The preferred genes encode L-arabinose isomerase, L-ribulokinase, L-ribulose phosphate 4-epimerase, xylose isomerase, xylulokinase, transaldolase and transketolase.
Expression of these genes is under the control of promoters that function in Zymomonas.
Strong glycolytic promoters are preferred. The promoters for glyceraldehyde-3-phosphate dehydrogenase and enolase are particularly preferred. Different genes may be under the control of different promoters or other expression altering sequences.
Some or all of the genes may be located together in the same vector or they may be on different vectors or integrated into the genome. Their expression may be such that the newly formed metabolic pathway is formed to enable the microorganism to ferment i: xylose, arabinose or other pentoses to ethanol. Preferably, the genes for L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4-epimerase, xylose isomerase, xylulokinase, transaldolase and transketolase are under the control of one or more functional pror oter: when in Zymomonas. The genes on a vector may be in any order, grouping or orientation relative to each other, providing that, if more than one promotor is present on the vector, the direction of transcription from one promotor does not adversely affect expression of the genes.
1 S-11- L i L In other preferred embodiments of the present invention, a genetic element comprising any two or more of the above described genes may be placed on the same vector. Particularly preferred is a plasmid containing both the transaldolase and the transketolase genes. These vectors preferably have the genes under the control of a promotor recognized by Zymomonas. The Examples below show plasmids pZBET, pZB4, pZB5 and pZB206, all of which are examples of vectors carrying DNA. encoding two or more of the above described genes.
The expression of the genes and the resulting functional activity of their corresponding gene products represent a new biochemical pathway that links pentose metabolism to the central Entner-Douderoff pathway in Zymomonas, conferring upon these cells, for the first time, the ability to grow on and ferment pentose directly to ethanol. The genes on a vector may be in any' orientation relative to the direction of transcription of these genes provided that they do not interfere with each other. The examples below have shown that the genes perform in essentially the same way regardless of orientation.
The microorganism(s) according to the present invention may be used alone or together to ferment xylose, arabinose and other pentose sugars contained in a medium to produce ethanol. The medium may include other fermentable sugars, such as glucose. If microbial growth is desired, other nutrients necessary for microbial growth may be added and the microorganism(s) allowed to reproduce.
Transaldolase and transketolase are key enzymes of the pentose phosphate pathway and are required for fermentation by Zymomonas of any pentose sugar which can 1 -12be converted to xylulose -5-P to ethanol. A preferred embodiment of the present invention is the expression of the genes for transaldolase and transketolase in Zymomonas in conjunction with any other set of genes that convert pentose sugar to Pentose sugars suitable for fermentation by the present invention include, but are not limited to xylose and arabinose. An example of added genes needed for fermentation of arabinose are L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4epimerase genes in addition to transaldolase and transketolase genes. An example of added genes needed for fermentation of xylose are xylose isomerase and xyloluldnase genes in addition to transaldolase and transketolase genes.
In an especially preferred embodiment of the invention, genes for xylose, arabinose and other pentose utilization, and genes for transaldolase and transketolase are obtained from organisms containing them, and are expressed in Zymomonas. Efficient transport of the pentoses into Zymomonas may be through native Zymomonas transport proteins, mutated Zymomonas transport proteins, or through the addition of new facilitated transporters introduced by cloning new transport genes into Zymomonas with or without mutagenesis of the cloned transport genes.
The step of microbial growth may be separate from fermentation. Xylose, arabinose, and other pentoses; or mixtures thereof may be used as a carbon source for microbial growth or one can separately culture the microorganisms on any medium (with or without a pentose) until sufficient numbers of microorganisms are present as a first step, and then add a medium containing a pentose for fermentation in a second step. If a
S
S
555
S
S
-13-
E
I
B
II I 1; I two step method is used, one may control expression of the genes in the new metabolic pathway so that greater expression occurs during the second step.
The choice of substrates will depend on cost and supply of the substrate to be fermented to ethanol. A typical low-cost supply of pentoses is from hemicellulose.
Xylose, arabinose and other pentoses are liberated from hemicellulosic materials by steam and/or an acid or alkali pretreatment. Smaller amounts of other sugars such as glucose are also separated during this pretreatment and are also fermented by Zymomonas to ethanol.
When the substrate is cellulosic material, the cellulose may be hydrolyzed to sugars simultaneously or separately and also fermented to ethanol. Since hemicellulose is generally easier to hydrolyze to sugars than cellulose, it is preferable to prehydrolyze the cellulosic material, separate the pentoses and then hydrolyze the cellulose by treatment with steam, acid, alkali, cellulases or combinations thereof to form glucose. Hexoses and pentoses may be fermented to ethanol simultaneously, sequentially, separately or together using the microorganisms of the present invention. If so desired, the hexoses may be fermented to ethanol by a different microorganism than the pentoses, such as yeast, natural Zynomonas, etc.
S. Many fermentation conditions are known per se as shown by the references mentioned in the Background of the Invention section above. Zymomonas mobilis is a facultative anaerobic bacterium. It has theoretical yields of ethanol from sugar of up to 97% which provides for little microbial growth, if so desired. The optimum pH conditions range from about 3.5 to about 7.5. Substrate concentrations of up to about 25% (based S on glucose), and under some conditions even higher, may be used. Unlike other ethanol -14- -14rr I i producing microorganisms, no oxygen is needed at any stage for microorganism survival.
Also unlike yeast, oxygen does not drastically reduce ethanol production or greatly increase cell growth. Agitation is not necessary but may enhance availability of substrate and diffusion of ethanol. Accordingly, the range of fermentation conditions may be quite broad. Likewise, any of the many known types of apparata may be used for the present invention.
The microorganisms according to the present invention may be used as a biologically pure culture or may be used with other ethanol producing microorganisms in mixed culture. Microorganisms able to ferment xylose can be mixed with microorganisms able to ferment arabinose. This mixed pentose fermenting culture can be cultured itself or can then be mixed with microorganisms able to ferment glucose. Biologically pure cultures are generally easier to optimize but mixed cultures may be able to maximize substrate utilization. One may also add enzyme to the fermenter to aid in the degradation of substrates or to enhance ethanol production. For example, cellulase may be added to degrade cellulose to glucose simultaneously with the fermentation of glucose to ethanol by microorganisms in the same fermenter. Likewise, a hemicellulase may be added to degrade hemicellulose.
In the preferred embodiment using genetically engineered Zymomonas, cultures are found to be relatively resistant to contamination by other microorganisms. Nonetheless, it is preferred to eliminate or disable preexisting deleterious microorganisms in the substrate before adding the Zymomonas culture.
*S
S V
S.
S..
f.
1: up I I After fermentation, the ethanol, which may achieve concentrations of up to about 13% is separated from the fermentation broth by any of the many conventional techniques known to separate ethanol from aqueous solutions. These methods include evaporation, distillation, solvent extraction and membrane separation. Particles of substrate or microorganisms may be removed before ethanol separation to enhance separation efficiency.
Once the fermentation is complete, excess microorganisms and unfermented substrate may be either recycled or removed in whole or in part. If removed, the microorganisms may be killed, dried or otherwise treated. This mixture may be used as animal feed, fertilizer, burnt as fuel or discarded.
o b While the discussion of the fermentation in this specification generally refers to a batch process, parts or all of the entire process may be performed continuously. To retain the microorganisms in the fermenter, one may separate solid particles from the fluids. This rnj be performed by centrifugation, flocculation, sedimentation, filtration, etc.
Alternatively, the microorganisms may be immobilized before retention in the fermenter or *41 :to provide easier separation.
Throughout the description and claims of the specification the word "comprise" and variations of the word, such as "comprising" and "comprises" is not intended to exclude other additives, components, integers or steps.
Unless specifically defined otherwise, all technical or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the -16al i
II
preferred methods and materials are better illustrated by the use of the following nonlimiting examples. The following examples are offered by way of illustration and not by way of limitation.
EXAMPLE 1 Isolation of the Xylose Isomerase and Xylulokinase Genes and Fusion to a Zymomonas GAP Promoter The Escherichia coli xylose isomerase and xylulokinase genes were initially obtained on a 7 kb HpaI/EcoRI restriction fragment from plasmid pLC1-3 (Clarke, L. and J. Carbon, 1977. Cell. 9:91-99). This DNA fragment was recovered from an agarose gel and subcloned into the SmaI/EcoRI sites in a pBlueScript plasmid (Stratagene, LaJolla, CA), which had been dephosphorylated with calf intestinal phosphatase, to generate the plasmid designated pBSX.
To remove excess DNA, pBSX was digested either with NsiI and Hind]I or with i NsiI and SmaI. After treatment with T4 DNA polymerase, the digested DNAs were separately ligated under dilute conditions favoring intramolecular ligation and were then transformed into E. coli HB101. Restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected deletion derivatives. The plasmid with the expected 587 bp NsiI/HindIII deletion was designated pXKH and contains the xylose isomerase and xylulokinase genes with the 3'-flanking xylose operon transcriptional terminator. The plasmid with the approximately 900 bp -1 -17- NsiI/SmaI deletion was designated pXKS and contains the xylose isomerase and xylulokinase genes without the 3'-flanking xylose operon transcriptional terminator.
To express the xylose isomerase and xylulokinase genes in Zymomonas, they were precisely fused to a Zymomonas glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter using a polymerase chain reaction (PCR)-mediated overlap extension technique.
This approach allowed precise fusion of the GAP promoter containing a ribosome binding site to the translational start codon of the xylose isomerase gene, thus ensuring that the expression of the xylose isomerase and xylulokinase genes would be regulated solely by the GAP promoter.
To accomplish this precise fusion, 308 bp of 5'-flanking DNA upstream of the GAP structural gene comprising the GAP promoter and the first 893 bp of the xylose isomerase structural gene were separately synthesized in a PCR using a common linking oligonucleotide primer. The individual DNA fragments were recovered from an agarose gel and combined in a second PCR in which the complementary ends at the 3'-end of the GAP promoter and the 5'-end of the xylose isomerase gene were annealed. The addition of the 5'-GAP and 3'-xylA primers then allowed the synthesis of a 1213 bp DNA fragment comprising a precise fusion of the GAP promoter to the 5'-end of the xylose isomerase gene.
The primers used to synthesize the 308 bp DNA fragment comprising the GAP promoter were based on the known DNA sequence of the 5'-flanking region of the GAP gene (Conway et al., 1987. J. Bacteriol. 169: 5653-5662) and included: et 0
A*.S
a*010 *ee.
0 0 a *004 &40000 0 0 000404 0
LLL~~
NotT. CCCTCGAGCGGCCGCGTTCGATCAACAACCCGAATCCTATCG-3' (SEQ ID NO:1) XhoI 3'-PRIMER: GTAGCTATTATATTCC-3'(SEQ ID NO:2) A 15 bp DNA sequence, comprising restriction sites for the restriction enzymes XhoI and NotI, was incorporated at the 5'-end of the synthesized GAP promoter. A 19 bp DNA sequence (BOLD), corresponding to the 5'-end of the xylose isomerase structural gene, was added to the 3'-end of the synthesized GAP promoter.
The primers used to synthesize the DNA fragment comprising the first 893 bp of the xylose isomerase structural gene were based on its known DNA sequence (Lawlis et al., 1984, Appl. Environ. Microbiol. 47: 15-21) and included:
GTTAGGAGAATAAACATGCAAGCCTATTTGACCAGCTCGATCG
CG-3'(SEQ ID NO:3) 3'-PRIMER: 5'-GGTTGGCGTCGACAGAAC-3'(SEQ ID NO:4) Sall An 18 bp DNA sequence (BOLD), corresponding to the 3'-end of the GAP promoter was added to the 5'-end of the synthesized xylose isomerase structural gene fragment *.it The 1213 bp DNA fragment, comprising a precise fusion of the GAP promoter to the 5'-end of the xylose isomerase gene was used to replace a 2.5 kb XhoI/SalI restriction fragment containing the native xylose isomerase promoter and 5'-end of the xylose .4 isomerase gene in plasmids pXKH and pXKS. The 1213 bp DNA fragment was digested with Sall and XhoI restriction endonucleases and ligated separately to the larger of the -19i two Sall/XhoI restriction fragments from plasmids pXKH and pXKS, previously purified by preparative agarose gel electrophoresis. The ligated DNA was used to transform E.
coli HB 101 and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmids, which have been designated as pGapXKH and pGapXKS. Digestion of either plasmid with the NotI restriction enzyme liberates the approximately 4.1 kb and 4.4 kb restriction fragments, respectively, containing the xylose isomerase and xylulokinase genes under the control of the GAP promoter, hereafter referred to as the GAP-xylA/xylB operon. This construct is shown in Figure 1.
EXAMPLE 2 Isolation and Linkage of the Transaldolase and Transketolase Genes in a Synthetic Operon Under Control of a Zymomonas ENO Promoter.
The Escherichia coli transaldolase and transketolase genes were isolated separately, synthetically linked and precisely fused to the Zymomonas enolase (ENO) promoter by PCR-mediated overlap extension. The transaldolase gene, localized within 0'minutes of the Escherichia coli genome, was obtained by PCR synthesis from total genomic DNA. The primers used to synthesize the 954 bp DNA fragment comprising the transaldolase gene were based on its known DNA sequence (Yura et al., 1992. Nucleic Acids Res. 20: 3305-3308) and included: ATTGACC-3'(SEQ ID 3'-PRIMER: TCC-3'(SEQ ID NO:6) XbaI A 33 bp DNA sequence (BOLD), corresponding to the 3'-end of the ENO promoter was added to the 5'-end of the synthesized transaldolase gene. A 21 bp DNA sequence comprising a restriction site for the restriction enzyme XbaI was incorporated at the 3'-end of the synthesized transaldolase gene to facilitate its subsequent subcloning.
The primers used to synthesize the 196 bp DNA fragment comprising the ENO promoter were based on the known DNA sequence of the 5'-flanking region of the ENO gene (Burnett et al., 1992. J. Bacteriol. 174: 6548-6553) and included: 5'-CCAGATCTCCAGTTACTCAATACG-3'(SEQ ID NO:7) BglI 3'-PRIMER:
GGTCAATTTGTCCGTCATATCGAAATTTTCTTAAAATCTTTAG
ACG-3'(SEQ ID NO:8) A 6 bp DNA sequence comprising a restriction site for the restriction enzyme BglII was incorporated at the 5'-end of the synthesized ENO promoter to facilitate its subsequent subcloning. An 18 bp DNA sequence (BOLD), corresponding to the 5'-end of the transaldolase gene was added to the 3'-end of the synthesized ENO promoter.
The transaldolase gene (tal) was then precisely fused to the ENO promoter by PCR-mediated overlap extension. To accomplish this precise fusion, the 196 bp of flanking DNA upstream of the ENO structural gene comprising the ENO promoter and -21- II I I I I 'a the 954 bp DNA fragment comprising the transaldolase gene were separately synthesized in a PCR using a common linking oligonucleotide primer. The individual DNA fragments were recovered from an agarose gel and then combined in a second PCR in which the complementary ends at the 3'-end of the ENO promoter and the 5'-end of the transaldolase gene were annealed. The addition of the 5'-ENO and 3'-tal primers then allowed the synthesis of a 1174 bp DNA fragment comprising a precise fusion of the ENO promoter to the transaldolase gene. This 1174 bp DNA fragment was digested with the XbaI restriction enzyme and then ligated to plasmid pUC18 that had been sequentially digested with the Smal restriction enzyme, treated with Taq polymerase in the presence of dTTP and finally digested with XbaI. The ligated DNA was used to transform E. coli DH5 a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pEnoTAL.
The transketolase gene (tktA) was obtained by PCR synthesis from E. coli W3110 genomic DNA. The primers used to synthesize the 2077 bp DNA fragment comprising the transketolase gene were based on its known DNA sequence (Sprenger, 1992. J. Bacteriol.
174: 1707-1708) and included: a a 5'-GCTCTAGACGATCTGGAGTCAAAATGTCC-3'(SEQ ID NO:9) XbaI 3'-PRIMER: 5'-AGATCTGCGCAAACGGACATTATCAAGG-3'(SEQID D BglII A 8 bp DNA sequence comprising a restriction site for the restriction enzyme XbaI was incorporated at the 5'-end of the tktA gene and a 7 bp DNA sequence comprising a a-22- -22i .I i IYL ii..~y*yi i;i- ii ii restricton site for the resuiction enzyme BglII was incorporated at the 3'-end of the tktA gene to facilitate its subsequent subcloning. Following PCR synthesis, the 2077 bp DNA fragment comprising the transketolase gene was purified by preparative agarose gel electrophoresis, digested with the XbaI restriction enzyme and ligated to plasmid pUC18 that had been sequentially digested with the HincII restriction enzyme, treated with Taq polymerase in the presence of dTTP and finally digested with Xbal. The ligated DNA was used to transform E. coli DH5 a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pUC-TKT.
'The transketolase gene was then subcloned downstream of the ENO-transaldolase fusion to create a synthetic operon comprised of the transaldolase and transketolase genes both under the control of the ENO promoter. To do this, plasmid pUC-TKT was digested with the XbaI and SphI restriction enzymes and the approximately 2 kb restriction fragment containing the transketolase gene was purified by preparative agarose gel electrophoresis and ligated to plasmid pEno-TAL that had been previously digested with the same restriction enzymes. The ligated DNA was used to transform E. coli DH5 a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pEnoTAL/TKT.
Digestion of this plasmid with the BglII restriction enzyme liberates an approximately 3 kb restriction fragment containing the transaldolase and transketolase operon under the control of the ENO promoter, hereafter referred to as the ENO-tal/tktA operon. This construct is also shown in Figure 1.
-23- L ~bl LI lli I*CI~ II~--II~-LL~ IC- -I 1- 'I i.
EXAMPLE 3 Construction of a Shuttle Vector and Transfer of the Xylose Metabolism and Pentose Phosphate Pathway Genes into Zymomonas A shuttle vector was constructed to permit the simultaneous transfer of the xylose metabolism and pentose phosphate pathway genes into Zymomonas. A small native 2.7 kb plasmid from Z. mobilis ATCC 10988 was purified by preparative agarose gel electrophoresis, linearized by digestion with the Aval restriction enzyme and ligated to the similarly digested plasmid pACYC184 (New England BioLabs, Beverly, MA) which had been dephosphorylated by treatment with calf intestinal phosphatase. The ligated DNA was used to transform E. coli HB101 and restriction analyses of the plasmid DNA from tetracycline-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pZB 186.
This plasmid was then modified to accept the xylose metabolism genes on a single NotI restriction fragment. Plasmid pZB 186 was linearized with the EcoRI restriction enzyme and the cohesive ends were filled-in by treatment with the Klenow fragment of DNA polymerase. NotI linkers were added according to standard methodology and then t the plasmid was digested with the NotI restriction enzyme and ligated under dilute
S
conditions favoring intramolecular ligation. The ligated DNA was used to transform E.
coli DH5 a and restriction analyses of the plasmid DNA from tetracycline-resistant 44 44 54 4 4444 -24- .i i j ~Y TI riiii;i transformants confirmed the presence of the added NotI restriction site in pZB 186. The modified plasmid has been designated pZB 188.
To introduce the ENO-tal/tkt operon into this shuttle vector, the approximately 3 kb Bgll restriction fragment from plasmid pEnoTAL/TKT was purified by preparative agarose gel electrophoresis and ligated to pZB 188 that had been sequentially passaged through E. coli JM110, linearized by digestion with the BclI restriction enzyme and dephosphorylated by treatment with calf intestinal phosphatase. The ligated DNA was used to transform E. coli DH5 a and restriction analyses of the plasmid DNA from tetracycline-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pZBET.
To also introduce the GAP-xylA/xylB operon into this plasmid, the approximately 4.1 kb and 4.4 kb NotI restriction fragments from plasmids pGapXKH and pGapXKS, respectively, were purified by preparative agarose gel electrophoresis and separately ligated to NotI linearized pZBET. The ligated DNA was used to transform E. coli HB 101 and restriction analyses of the plasmid DNA from tetracycline-resistant transformants *confirmed the presence of the expected plasmids. The plasmid containing the GAPxylA/xylB operon from pGapXKH in clockwise orientation and the ENO-tal/tkt operon from pEnoTAL/TKT in counterclockwise orientation has been designated pZB4. The plasmid containing the GAP-xylA/xylB operon from pGapXKS in clockwise orientation and the ENO-tal/tkt operon from pEnoTAL/TKT in counterclockwise orientation has been designated pZB5. The orientation of pZB4 and pZB5 may be viewed in Figure 1.
S
S. l-_ i Plasmids pZB4 and pZB5 were separately transformed into Z. mobilis CP4 by electroporation of approximately 109 cells/ml with 4 pg DNA in 40 pi of 10% (w/v) glycerol at 16 kv/cm, 200 and 25pF. After electroporation, the cells were allowed to recover at 30 0 C for 3-16 hours in a liquid medium comprised of 5% glucose, 10% yeast extract (Difco), 5% Tryptone (Difco), 0.25% .ammonium sulfate, 0.02% potassium phosphate, dibasic and ImM magnesium sulfate. Transformants containing pZB4 and were isolated following anaerobic incubation at 30 0 C for 2 or more days in the same medium additionally containing 1.5% agar and tetracycline (20 pg/ml) and were subsequently confirmed by restriction analyses of the plasmid DNA from tetracyclineresistant transformants.
Enzymatic analyses of Z. mobilis CP4 (pZB4) demonstrated the presence of xylose isomerase (0.35 U/min/mg), xylulokinase (1.4 U/min/mg), transaldolase (1.9 U/min/mg) and transketolase (0.27 U/min/mg) activities and thus confirmed the expression of all four genes. These enzymatic activities were either undetectable or significantly lower (xylose isomerase, 0.008/min/mg; xylulokinase, undetectable; transaldolase, 0.014 U/min/mg; and t transketolase, 0.032 U/min/mg) in the control strain containing the shuttle vector alone (CP4 [pZB186]).
e* 4 :EXAMPLE 4 Fermentation Performance of Recombinant Zymomonas Containing the Xylose Metabolism and 4 Pentose Phosphate Pathway Genes t- -26m i} 1 W_ I) 4r-.
~ara~ The fermentation performance of the recombinant Zymomonas containing the xylose isomerase, xylulokinase, transaldolase and transketolase genes was evaluated in a medium comprising 1% yeast extract (Difco), 0.2% potassium phosphate, dibasic and either 5% glucose, or 5% xylose, or 2.5% glucose and 2.5% xylose.
The recombinant Zymomonas strains were first propagated at 30°C in the above medium containing 5% glucose or xylose in a bottle with 80 ml of working volume without agitation until late log-phase. The cells were then inoculated to 200 ml of the above fermentation medium in a 250 ml flask at an initial OD 60 0 =0.05-0.1. The cultures were grown at 30°C under anaerobic conditions using CO0-traps with gentle shaking (150 rpm) for mixing. The cell growth was monitored as optical density at 600 nm. The residual sugars as well as ethanol concentrations were determined on HPLC (HP 1090L) (Hewlett Packard, Wilmington, DE) using a Bio-Rad Aminex HPX-97H column.
The results presented in Figure 2 show that in contrast to the control strain containing the shuttle vector alone (CP4[pZB 186]), the recombinant containing the added xylose isomerase, xylulokinase, transaldolase and transketolase genes demonstrated growth and ethanol production from xylose as a carbon source. The recombinant strain produces ethanol from glucose as efficiently as the control strain at 94% of theoretical yield. The recombinant strain additionally produces ethanol from xylose at 84% of theoretical yield in 79 hours. Furthermore, in the combined presence of glucose and xylose, the recombinant strain ferments both sugars simultaneously to ethanol at 88% of 04 0 4s 444.a *o 4 404 *0 4r 4040 4.4 4 4 4* 0 0444 *0*0
-J
I 0 40*404 -27-
II
I-L- theoretical yield within 48 hours, thus providing the foundation for advanced process designs with cofermentation of mixed-sugar feedstocks.
EXAMPLE Isolation of the L-Arabinose Isomerase, L-Ribulokinase,.
and L-Ribulose 5-Phosphate 4-Epimerase Genes and Fusion to a Zymomonas GAP Promoter The L-arabinose isomerase (araA), L-ribulokinase (araB), and L-ribulose phosphate 4-epimerase (araD) genes were isolated separately from the native araBAD operon of Escherichia coli B/r (Lee et al., 1986. Gene 47: 231-244) using polymerase chain reaction (PCR) synthesis, and synthetically linked to form a new araBAD operon.
To express the L-ribulokinase, L-arabinose isomerase, and L-ribulose 5-phosphate 4epimerase (araBAD) genes in Zymomonas, the genes were precisely fused to a Zymomonas glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter using a PCR- *mediated overlap extension technique. This approach allowed precise fusion of the GAP l* I *it t promoter containing a ribosome binding site to the translational start codon of the Lribulokinase gene, thus ensuring that the expression of the araBAD genes would be S regulated solely by the GAP promoter. To accomplish this precise fusion, 308 bp of I. flanking DNA upstream of the GAP structural gene comprising the GAP promoter and the 604 first 582 bp of the araB structural gene were separately synthesized in a PCR using a a 1 common linking oligonucleotide primer. The individual DNA fragments were recovered -28i from an agarose gel and combined in a second PCR in which the complementary ends at the 3'-end of the GAP promoter and the 5'-end of the araB gene were annealed. The addition of the 5'-GAP and 3'-araB primers then allowed the synthesis of a 902 bp DNA fragment comprising a precise fusion of the GAP promoter to araB gene.
The primers used to synthesize the 308 bp DNA fragment comprising the GAP promoter were based on the known DNA sequence of the 5'-flanking region of the GAP gene (Conway et al., 1987. J. Bacteriol. 169: 5653-5662) and included: NotI 5'-PRIMER: GGAATTCGCGGCCGCGTTCGATCAACAACCCGAATCC-3'(SEQ ID NO:11) EcoRI 3'-PRIMER: GTAGCTATTATATTCC-3'(SEQ ID NO: 12) A 15 bp DNA sequence, comprising restriction sites for the restriction enzymes EcoRI and NotI, was incorporated at the 5'-end of the synthesized GAP promoter. A 16 bp DNA sequence (BOLD), corresponding to the 5'-end of araB gene, was added to the C C C 3'-end of the synthesized GAP promoter.
The primers used to synthesize the DNA fragment comprising the first 582 bp of the araB gene were based on its known DNA sequence (Lee et al., 1986, Gene 47: 231- 244) and included: 5'-PRIMER: GTTAGGAGAAACATGGCGATTGCAATTGGCCTCGATTTTGGC-3' (SEQ ID NO:13) -29- 3'-PRIMER: 5'-CGGGCGGGTGGTACCGGAAAG-3' (SEQ ID NO:14) KpnI A 15 bp DNA sequence (BOLD), corresponding to the 3'-end of the GAP promoter was added to the 5'-end of the synthesized araB gene fragment.
Following the second PCR synthesis, the 902 bp PCR fragment was purified by preparative agarose gel electrophoresis and digested with EcoRI and KpnI to generate the 891 bp EcoRI-KpnI DNA fragment, comprising a precise fusion of the GAP promoter to the araB gene.
The 2679 bp DNA fragment, comprising the 3'-end of the araB and araA genes was obtained by PCR synthesis from the Escherichia coli B/r chromosome. The primers used to synthesize this DNA fragment were based on its known DNA sequence (Lee et al., 1986, Gene 47: 231-244) and included: 5'-PRIMER: 5'-CTTTCCGGTACCACCCGCCCG-3' (SEQ ID KpnI 3'-PRIMER: CTAACATGTTGACTCCTTCTCTAGACTTAGCGACGAAATCCGTAATACAC-3' (SEQ ID NO:16) XbaI S A 26 bp DNA sequence, comprising restriction site for Xbal, was incorporated at the 3'-end of the araA gene. Following PCR synthesis, the 2679 bp PCR fragment was purified by preparative agarose gel electrophoresis, digested with KpnI and XbaI to generate the 2652 bp KpnI-XbaI DNA fragment, comprising the 3'-end of the araB and the araA genes.
6 444* 9 I *,1 To remove the repetitive extragenic palindromic sequences between araA and araD in the native araBAD operon, the araD gene encoding L-ribulose 5-phosphate 4epimerase was isolated separately from the Escherichia coli B/r chromosome using PCR synthesis, then linked to end of araA to form a new araBAD operon. The primers used to synthesize the 916 bp DNA fragment comprising the araD gene were based on its known DNA sequence (Lee et al., 1986, Gene 47: 231-244) and included: CGGATTTCGTCGCTAAGTCTAGAGAAGGAGTCAACATGTTAGAAGATCTC-3' (SEQ ID NO:17) XbaI 3'-PRIMER: 5'-CCCCCAAGCTTGCGGCCGCGGCCCGTTGTCCGTCGCCAG-3' (SEQ ID NO:18) HindIII NotI A 23 bp DNA sequence, comprising a restriction site for XbaI, was incorporated at the 5'-end of the araD gene and a 19 bp DNA sequence, comprising restriction sites for HindIII and NotI, was incorporated at the 3'-end of the araD gene to facilitate its subsequent subcloning. Following PCR synthesis, the 916 bp PCR fragment was purified by preparative agarose gel electrophoresis and digested with the XbaI and HindIII to generate the 892 bp DNA fragment, comprising the araD gene, that was ligated to plasmid pUC18 that had been digested with the same restriction enzymes. The ligated .DNA was used to transform E. coli DH5a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pUC-araD.
-31-
I
~I r 'e To construct a new araBAD operon, araD was linked to the 3'-end of the araA.
To do this, the 2652 bp KpnI-XbaI DNA fragment, comprising the 3'-end of the araB and the araA genes was ligated to pUC-araD that had been digested with KpnI and XbaI restriction enzymes. The ligated DNA was used to transform E. coli DH5a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirrried the presence of the expected plasmid, which has been designated as pUC-araB'AD. The plasmid pUC-araB'AD contains the partial new araBAD operon.
The plasmid pBRMCS which was constructed by inserting the EcoRI-HindIII multiple cloning site fragment of pUC18 into the EcoRI and HindII sites in pBR322, was used to subclone the new Pap-araBAD operon (see below). The 3544 bp ara-B'AD fragment was isolated by preparative agarose gel electrophoresis following digestion of pUC-araB'AD with KpnI and HindIl, and ligated to pBRMCS that had been digested with the same restriction enzymes. The ligated DNA was used to transform E. coli and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pBRMCSaraB'AD. The previously obtained 891 bp EcoRI-KpnI DNA fragment, comprising a precise fusion of the GAP promoter to the araB gene, was then ligated to pBRMCSaraB'AD that had been digested with KpnI and EcoRI restriction enzymes. The ligated DNA was used to transform E. coli DH5a and restriction analyses of the plasmid DNA from ampicillin-resistant transformants confirmed the presence of the expected plasmid, which has been designated as pBR gap-araBAD. Digestion of this plasmid with the NotI restriction enzyme liberates an approximately 4.4 kb restriction fragment containing the ,1 -32- I .t 4. L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4-epimerase operon under the control of the GAP promoter, hereafter referred to as the Pg,,-araBAD operon (Figure 3).
EXAMPLE 6 Construction of a Recomibinant Plasmid Containing Arabinose Metabolism and Pentose Phosphate Pathway Genes and Transfer into Zymomonas The plasmids pZBET containing the P,,,,-taltkt A operon comprising the transaldolase and transketolase genes from Escherichia coli cloned precisely under the control of the Z. mobilis enolase (ENO) promoter in both clockwise and counterclockwise orientations were previously constructed in Example 2. To introduce the Pgap-araBAD operon into this plasmid, the approximately 4.4 kb NotI restriction fragment from plasmids pBR gap-araBAD was purified by preparative agarose gel electrophoresis and separately ligated to NotI linearized pZBET. The ligated DNA was used to transform E. coli DH5a and restriction analyses of the plasmid DNA from tetracycline-resistant transformants confirmed the presence of the expected plasmids. The plasmid containing the P,,,-talltkt A operon and the Pg,,-araBAD operon in clockwise orientations has been
SC-
9 designated pZB200. The plasmid containing the Pe,,-tal/tkt A operon in clockwise orientation and the Pgap-araBAD operon in counterclockwise orientation has been designated pZB202. The plasmid containing the Peno-tal/tkt A operon in counterclockwise orientation and the Pgap-araBAD operon in clockwise orientation has been -33- 3; i i designated pZB204. The plasmid containing the Peno-tal/tkt A operon and the PparaBAD operon in counterclockwise orientations has been designated pZB206 (Figure 3).
Plasmids pZB200, pZB202, pZB204 and pZB206 were separately transformed into Z. mobilis ATCC 39676 by electroporation of approximately 109 cells/ml with 1. 2 to 3.0 pg DNA in 40 pl.of 10% glycerol at 16 kv/cm, 2002 and 25pF. After electroporation, the cells were allowed to recover at 30 0 C for 3-16 hours in a liquid medium comprised of 5% glucose, 10% yeast extract (Difco), 5% Tryptone (Difco), 0.25% ammonium sulfate, 0.02% potassium phosphate, dibasic and ImM magnesium sulfate. Transformants containing pZB200, pZB202, pZB204 and pZB206 were isolated following anaerobic incubation at 30 0 C for 2 or more days in the same medium additionally containing 1.5% agar and tetracycline (20 pg/ml) and were subsequently 0 30 confirmed by restriction analyses of the plasmid DNA from tetracycline-resistant transformants.
o EXAMPLE 7 Fermentation Performance of Recombinant Zymomonas Containing the Arabinose Metabolism and Pentose Phosphate Pathway Genes The fermentation performance of the recombinant Zymomonas containing the L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4-epimerase, transaldolase and transketolase genes was evaluated in a medium comprised of 1% yeast extract (Difco), 0.2% potassium phosphate, dibasic and either 2.5% arabinose or 2.5% arabinose and 2.5% glucose. The recombinant Zymomonas strains were first propagated at 30 °C in -34above medium containing 5% glucose till late logphase. The cells were then inoculated to ml of fermentation medium in a 100 ml bottle at an initial OD 60 o=0.15 at 600 nm. The culture was grown at 30 °C or 37 °C without shaking.
The results presented in Figure 4 show that, in contrast to the control strain containing the shuttle vector alone (pZB 186), the recombinant strain containing the added L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4-epimerase, transaldolase and transketolase genes (pZB206) demonstrates growth on and ethanol production from arabinose as a sole carbon source. The recombinant strain of the present invention produces ethanol from arabinose at 91% or 96% of theoretical consumed sugar yield in 96 0 hours at 30 0 C or 37°C, respectively. Furthermore, in the combined presence of glucose and arabinose, the recombinant strain ferments both sugars to ethanol at 89% or 96% of o 6 theoretical consumed sugar yield in 96 hours at 30 0 C or 37°C, respectively, thus providing i; the foundation for advanced process designs requiring cofermentation of mixed-sugar S feedstocks.
C tr err EXAMPLE 8 c Using Recombinant Zymomonas Containing the Xylose Metabolism and Pentose Phosphate Pathway Genes to Coferment Glucose and Xylose The fermentation performance of the recombinant Zymomonas containing the Dxylose isomerase, D-xylulokinase, transaldolase, and transketolase genes was evaluated on a mixture of 3.5% D-xylose and 6% D-glucose. Fermentation was carried out in an unsparged 500 mL working volume fermenter operating at a temperature of 37 0 C, an 1 agitation rate of 150 rpm, and was inoculated with approximately 0.6 g of dry cell mass per liter (g DCM/L). The fermentation pH was controlled at 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium comprised 1% (w/v) yeast extract (Difco) and 0.2% dibasic potassium phosphate; tetracycline was added at a level of 10 mg/L to ensure plasmid retention..
The recombinant strain from Example 3 containg the added genes encoding enzymes for xylose utilization fermented the mixture of 6% glucose and 3.5% (w/v) xylose to about 42 g/L ethanol in 48 hours to achieve an overall (net) yield of available sugars of 86% of theoretical. See Figure EXAMPLE 9 Using Recombinant Zymomonas Containing the Xylose Metabolism and Pentose Phosphate Pathway Genes to Coferment Cellulose, Glucose and Xylose The fermentation performance of the recombir ant Zymomonas containing the D-xylose isomerase, D-xylulokinase, transaldolase, and transketolase genes as produced in Example 3 was evaluated on a mixture of 3.5% D-xylose, 3% D-giucose and 3% Sigmacell-50 microcrystalline cellulose (Sigma). CPN cellulase enzyme complex (Iogen) was added at a loading of 25 filter paper units per gram of cellulose (FPU/g cellulose) to hydrolyze the cellulose. Fermentation was carried out in an -36- Ii I xmle a vlae namxueo wv -lc n (g DCM/L). The fermentation pH was controlled at 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium comprised 1% yeast extract (Difco) and 0.2% dibasic potassium phosphate; tetracycline was added at a level of 10 mg/L to ensure plasmid retention.
In the presence of exogenous cellulase, the recombinant strain produced by Example 3 above, containing the added genes encoding for xylose utilization fermented the mixture of 3% cellulose, 3% glucose and 3.5% xylose to about g/L ethanol in 120 hours to achieve an overall (net) yield on all potentially available sugars above 80% of theoretical. See Figure 6.
EXAMPLE Using Recombinant Zymomonas Containing the Xylose Metabolism and Pentose Phosphate Pathway Genes to Coferment Cellulose and Xylose The fermentation performance of the recombinant Zymomonas containing the c D-xylose isomerase, D-xylulokinase, transaldolase, and transketolase genes was evaluated on a mixture of 3.5% D-xylose and 6% Sigmacell-50 microcrystalline &oo cellulose (Sigma). CPN cellulase enzyme complex (logen) was added at a loading of filter paper units per gram of cellulose (FPU/g cellulose) to hydrolyze the cellulose.
Fermentation was carried out in an unsparged 500 mL working volume fermenter operating at a temperature of 37 0 C and an agitation rate of 150 rpm, and was inoculated with approximately 0.6 g of dry cell mass per liter (g DCM/L). The fermentation pH was -37- L;72 r"
A
controlled at 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium comprised 1% yeast extract (Difco) and 0.2% dibasic potassium phosphate; tetracycline was added at a level of 10 mg/L to ensure plasmid retention.
As shown in Figure 7, in the presence of exogenous cellulase, the recombinant strain produced by Example 3 above, containing the added genes encoding for xylose utilization fermented the mixture of 6% cellulose and 3.5% xylose to about 38 g/L ethanol in 120 hours to achieve an overall (net) yield on all potentially available sugars above 72% of theoretical.
EXAMPLE 11 Using Recombinant Zymomonas Containing the Arabinose Metabolism and Pentose Phosphate Pathway Genes to Coferment SCellulose, Glucose and Arabinose 0 Fermentation of mixtures of L-arabinose, D-glucose, and cellulose can be carried out using the recombinant Zymomonas containing the L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4-epimerase, transaldolase, and transketolase genes in a manner similar to that described in Example 7 above. Using this approach, o S yields based on total potentially available sugars (D-glucose L-arabinose) of greater than 75% could be achieved. For example, mixtures of 2.5% L-arabinose, D-glucose, and 2.5% Sigmacell-50 microcrystalline cellulose (Sigma) could be -38fermented in an unsparged 500 mL working volume fermenter operating at a temperature of 37°C, an agitation rate of 150 rpm, using an inoculum loading of approximately 0.6 g of dry cell mass per liter (g DCM/L). In this case, a cellulase enzyme complex such as CPN cellulase (logen) would be added at an appropriate loading, such as 25 filter paper units per gram of cellulose (FPU/g cellulose), to hydrolyze the cellulose. Fermentation pH would be controlled at an appropriate level to uncouple fermentation from growth, such as pH 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium would be comprised of 1% yeast extract (Difco) and 0.2% dibasic potassium phosphate, and tetracycline added at a level of approximately 10 mg/L to ensure plasrnid retention.
:EXAMPLE 12 Using Recombinant Zymomonas Containing the Arabinose Metabolism and Pentose Phosphate Pathway Genes to Coferment Cellulose and Arabinose i Fermentation of mixtures of L-arabinose and cellulose can be carried out using the recombinant Zymomonas containing the L-arabinose isomerase, L-ribulokinase, L-ribulose ii 4-epimerase, transaldolase, and transketolase genes in a manner similar to that described in Example 10 above. Using this approach, yields based on total potentially available sugars (D-glucose L-arabinose) of greater than 70% could be achieved. For example, mixtures of 2.5% L-arabinose and 5% Sigmacell-50 microcrystalline -39- I i j -I -c~ cellulose (Sigma) could be fermented in an unsparged 500 mL working volume fermenter operating at a temperature of 37 0 C, an agitation rate of 150 rpm, using an inoculum loading of approximately 0.6 g of dry cell mass per liter (g DCM/L). In this case, a cellulase enzyme complex such as CPN cellulase (logen) would be added at an appropriate loading, such as 25 filter paper units per gram of cellulose (FPU/g cellulose), to hydrolyze the cellulose. Fermentation pH would be controlled at an appropriate level such as pH 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium would be comprised of 1% yeast extract (Difco) and dibasic potassium phosphate, and tetracycline added at a level of approximately 10 mg/L to ensure plasmid retention.
b o cc a ccc uS
B
ccc.
ccc.
a bb bnbb b..c a :a EXAMPLE 13 Using Mixed Cultures of the Recombinant Zymomonas Containing the Xylose Metabolism and Pentose Phosphate Pathway Genes in Combination with the Recombinant Zymomonas Containing the Arabinose Metabolism and Pentose Phosphate Pathway Genes to Coferment Mixtures of Xylose and Arabinose and Glucose, Mixtures of Xylose and Arabinose and Cellulose, or Mixtures of Xylose and Arabinose and Glucose and Cellulose Fermentation of mixtures of L-arabinose, D-xylose, D-glucose, and cellulose can be carried out by using a mixed cultured comprised of the recombinant Zymomonas containing the L-arabinose isomerase, I -ribulokinase, L-ribulose 4-epimerase, transaldolase, and transketolase genes in combination with the recombinant IL I; Y i Zymomonas containing the D-xy!- isomerase, D-xylulokinase, tranaldolase, and transketolase genes. Using this approach, yields based on total potentially available sugars (D-glucose D-xylose L-arabinose) of greater than 70% could be achieved. For example, mixtures of 2% L-arabinose, 2% D-xylose, 2% D-glucose, and 2% Sigmacell-50 microcrystalline.cellulose (Sigma) could be fermented in an unsparged 500 mL working volume fermenter operating at a temperature of 37 C, an agitation rate of 150 rpm, using an inoculum loading of approximately 0.3 g of dry cell mass per liter (g DCM/L) of the arabinose-fermenting strain in combination with approximately 0.3 g of dry cell mass per liter (g DCM/L) of the xylose-fermenting strain.
Inoculum ratios of the two recombinant strains can be varied from 1:1, as recited herein, to equal the proportion of the arabinose:xylose ratio in the mixture. In this particular .j example, since cellulose is present, a cellulase enzyme complex such as 25 filter paper units per gram of cellulose (FPU/g) is added to hydrolyze the cellulose. If a mixture of 0' only L-arabinose, D-xylose, and D-glucose were to be fermented, it would not be necessary to add cellulase enzyme complex. Fermentation pH would be controlled at an appropriate level such as pH 5.2 by the automatic addition of concentrated potassium hydroxide. The fermentation medium would be comprised of 1% yeast extract (Difco) and 0.2% dibasic potassium phosphate, and tetracycline added at a level of approximately 10 mg/L to ensure retention of the plasmids by both of the strains. Since growth would be minimized by operating at 37 C, one of the strains would not outcompete or overtake the other.
-41-
I'
i
I
ii It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation.
All references mentioned in this application are incorporated by reference.
.0o 0 oe
C
C.
00 0 o 0m •loo *Oft S *0 0 i .flC a« ••c a o o 0 O*4e a i* -42- -43- SEQUENCE LISTING GENERAL INFORMATION: APPLICANT: Picataggio, Stephen Zhang, Min Eddy, Christina Deanda, Kristine Finkelstein, Mark Mohaghegli, Ali Newman, Mildred McMillan, James (ii) TITLE OF INVENTION: Pentose Fermentation by Recombinant Zymomonas (iii) NUMBER OF SEQUENCES: 18 (iv) CORRESPONDENCE ADDRESS: ADDRESSEE: NATIONAL RENEWABLE ENERGY LABORATORY STREET: 1617 Cole Blvd.
CITY: Golden STATE: CO S(E) COUNTRY: USA ZIP: 80401-3393 COMPUTER READABLE FORM: MEDIUM TYPE: Floppy disk COMPUTER: IBM PC compatible OPERATING SYSTEM: PC-DOS/MS-DOS SOFTWARE: ASCII(DOS)TEXT (vi) CURRENT APPLICATION DATA: APPLICATION NUMBER: US 08/422,424 and US 08/421,996 FILING DATE: 14-APR-1995
CLASSIFICATION:
(vii) PRIOR APPLICATION DATA APPLICATION NUMBER: US 08/228,303 FILINGDATE: 15-APR-1994 (viii) ATTORNEY/AGENT INFORMATION: NAME: O'CONNOR, EDNA REGISTRATION NUMBER: 29,252 REFERENCE/DOCKET NUMBER: NREL 95-26 and 27 -44- (ix) TELECOMMUNICATION INFORMATION: TELEPHONE: (303)384-7573 TELEFAX: (303)384-7499 INFORMATION FOR SEQ ID NO:1: SEQUENCE CHARACTERISTICS: LENGTH: 42 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1: SCCCTCGAGCG GCCGCGTTCG ATCAACAACC CGAATCCTAT CG INFORMATION FOR SEQ ID NO:2: o 8 SEQUENCE CHARACTERISTICS: LENGTH: 57 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO S FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: GGTCAAAATA GGCTTGCATG TTTATTCTCC TAACTTATTA AGTAGCTATT
ATATTCC
INFORMATION FOR SEQ ID NO:3: SEQUENCE CHARACTERISTICS: LENGTH: 46 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GTTAGGAGAA TAAACATGCA AGCCTATTTT GACCAGCTCG ATCGCG INFORMATION FOR SEQ ID NO:4: SEQUENCE CHARACTERISTICS: LENGTH: 18 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: GGTTGGCGTC GACAGAAC INFORMATION FOR SEQ ID SEQUENCE CHARACTERISTICS: LENGTH: 48 bases TYPE: nucleic acid I eI! -46- STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL:
NO
(iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID CGTCTAAAAG ATTTTAAGAA AGGTTTCGAT ATGACGGACA AATTGACC INFORMATION FOR SEQ ID NO:6: SEQUENCE CHARACTERISTICS: LENGTH: 49 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear 9 (ii) MOLECULE TYPE: DNA (genomic) S (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: .:..CATTTGACT CCAGATCTAG ATTACAGCAG ATCGCCGATC ATTTTTTCC, INFORMATION FOR SEQ ID NO:7: i SEQUENCE CHARACTERISTICS: LENGTH: 24 bases S* TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) I i (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: CCAGATCTCC AGTTACTCAA TACG INFORMATION FOR SEQ ID NO:8: SEQUENCE CHARACTERISTICS: LENGTH: 47 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO S (iv) ANTI-SENSE: NO S FRAGMENT TYPE: internal S (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: GGTCAATTTG TCCGTCATAT CGAAATTTTC TTAAAATCTT TTAGACG INFORMATION FOR SEQ ID NO:9: SEQUENCE CHARACTERISTICS: LENGTH: 29 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal i -48- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: GCTCTAGACG ATCTGGAGTC AAAATGTCC INFORMATION FOR SEQ ID SEQUENCE CHARACTERISTICS: LENGTH: 28 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID AGATCTGCGC AAACGGACAT TATCAAGG INFORMATION FOR SEQ ID NO:11: SEQUENCE CHARACTERISTICS: LENGTH: 37 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: GGAATTCGCG GCCGCGTTCG ATCAACAACC CGAATCC INFORMATION FOR SEQ ID NO:12: -!i
II
-49- SEQUENCE CHARACTERISTICS: LENGTH: 54 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: CAATTGCAAT CGCCATGTTT ATTCTCCTAA CTTATTAAGT AGCTATTATA TTCC INFORMATION FOR SEQ ID NO:13: SEQUENCE CHARACTERISTICS: LENGTH: 42 bases TYPE: nucleic acid S STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO C I (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal S (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: GTTAGGAGAA ACATGGCGAT TGCAATTGGC CTCGATTTTG GC INFORMATION FOR SEQ ID NO: 14: SEQUENCE CHARACTERISTICS: LENGTH: 21 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear V 1
V
(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: CGGGCGGGTG GTACCGGAAA G INFORMATION FOR SEQ ID SEQUENCE CHARACTERISTICS: LENGTH: 21 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL:
NO
(iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID CTTTCCGGTA CCACCCGCCC G INFORMATION FOR SEQ ID NO: 16: SEQUENCE CHARACTERISTICS: LENGTH: 50 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO -51- FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: CTAACATGTT GACTCCTTCT CTAGACTTAG CGACGAAATC CGTAATACAC INFORMATION FOR SEQ ID NO: 17: SEQUENCE CHARACTERISTICS: LENGTH: 50 bases TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: 'T Q ID NO:17: SCGGATTTCGT CGCTAAGTCT AGAGAAGGAG TCAACATGTT AGAAGATCTC INFORMATION FOR SEQ ID NO:18: SEQUENCE CHARACTERISTICS: LENGTH: 39 bases S(B) TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic)
C
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE:
NO
FRAGMENT TYPE: internal (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CCCCCAAGCT TGCGGCCGCG GCCCGTTGTC CGTCGCCAG i i iC i_
Claims (24)
1. The microorganism Zymomonas mobilis containing exogenous genes encoding L-arabinose isomerase, L-ribulokinase, L-ribulose-5-phosphate-4- epimerase, transaldolase and transketolase which is capable of growing on arabinose as a sole carbon source and fermenting said arabinose to ethanol, wherein said microorganism without said genes is incapable of fermenting said arabinose to ethanol.
2. The microorganism of claim 1, wherein said transaldolase and transketolase genes are expressed under the control of the Z.mobilis enolase promoter.
3. The microorganism of claim 1, wherein said exogenous gene encodes an enzyme selected from the group consisting of: L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4- epimerase genes are expressed under the control of the Z.mobilis glyceraldehyde-3-phosphate dehydrogenase promoter.
4. The microorganism of any one of claims 1 to 3, wherein said exogenous genes are obtained from a microorganism selected from the group consisting of E. coli, Xanthomonas, Klebsiella, Rhodobacter, Flavobacterium, Acetobacter, Glaconobacter, Rhizobium, Agrobacterium, Salmonella and Pseudomonads.
5. The microorganism of any one of claims 1 to 4, wherein said exogenous 0 jgenes are expressed under the control of one or more promoters located 5' to C CJ said genes, whereby said gene is expressed in said microorganism.
6. The microorganism of any one of claims 1 to 5, wherein the genes are integrated into the host genome.
7. The microorganism of any one of claims 1 to 5, wherein said genes are contained on a vector.
8. The microorganism of claim 7, wherein said vector is a plasmid.
9. A vector for the transformation of Zymomonas mobilis comprising genes encoding L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4- epimerase, transaldolase and transketolase, and at least one promoter selected from the group consisting of Z. mobilis glyceraldehyde-3-phosphate ST i C\W\V NWoMRDoFIONAJCVODELETOS05.DOC .OF. t' iftim* vi 4- 04 0 00* 014 1 1 11 11 I tr 'r t SI t r( C 444 t C 4 I dehydrogenase and Z.mobilis enolase recognised by Zymomonas mobilis which regulates the expression of the genes.
The microorganism of claim 1, which contains a vector comprising genes encoding L-arabinose isomerase, L-ribulokinase, L-ribulose 5-phosphate 4- epimerase, transaldolase and transketolase, and at least one promoter selected from the group consisting of Z. mobilis glyceraldehyde-3-phosphate dehydrogenase and Z.mobilis enolase recognised by Z.mobilis which regulates the expression of the genes.
11. The microorganism of claim 4, containing exogenous genes which encode L-arabinose isomerase, L-ribulokinase, and L-ribulose 5-phosphate 4- epimerase, expressed under the control of the Z.mobilis glyceraldehyde-3- phosphate dehydrogenase promoter, and exogenous genes which encode transaldolase and transketolase, expressed under the control of the Z.mobilis enolase promoter.
12. The microorganism any one of claims 1 to 8, 10 or 11', wherein said genes are coordinately expressed.
13. A process for producing ethanol comprising: providing a feedstock containing arabinose, adding the microorganism Zymomonas mobilis to the feedstock, said microorganism containing exogenous genes that encode L-arabinose isomerase, L-ribulokinase and L- ribulose-5-phosphate-4-epimerase, transaldolase and transketolase which import arabinose to ethanol fermentation capability and wherein said microorganism without said genes is incapable of fermenting said arabinose to ethanol allowing the microorganism to ferment the arabinose in the feedstock to ethanol, and separating the ethanol.
14. A process for producing ethanol comprising: providing a feedstock containing xylose, adding the microorganism Zymomonas mobilis to the feedstock, said microorganism containing exogenous genes that encode xylose isomerase, xylulokinase, transaldolase and transketolase and capable of growing on xylose as a sole carbon source and fermenting said xylose to ethanol at about 88% of theoretical yield and wherein said microorganism C: WINWORDIONAMPJCNODELETElSOS2.DOC V OF II i- r-a3 rrrax*~-r~rr 54 without said genes is incapable of growing on or fermenting said xylose in the feedstock to ethanol, allowing the microorganism to ferment the xylose in the feedstock to ethanol, and separating the ethanol.
The process of claim 13 or 14, wherein said exogenous genes are expressed under the control of one or more promoters selected from the group consisting of Z.mobilis glyceraldehyde-3-phosphate dehydrogenase and Z.mobilis enolase located 5' to said genes, whereby said genes are expressed in said microorganism to confer upon said microorganism an ability to ferment arabinose directly to ethanol.
16. The process of any one of claims 13 to 15, wherein the exogenous genes are integrated into the host genome.
17. The process of any one of claims 13 to 15, wherein the exogenous genes are located on a vector.
18. A process for producing ethanol comprising, providing a mixed sugar 15 feedstock consisting essentially of at least two sugars selected from the group o.E consisting of glucose, fructose, sucrose, xylose and arabinose adding the microorganism Zymomonas mobilis containing exogenous genes to the feedstock, allowing fermentation to ethanol from sugar contained in the e 0. feedstock to occur, and separating the ethanol, 20 wherein the microorganism is Zymomonas mobilis containing exogenous genes from a microorganism selected from the group consisting E. coli, Xanthomonas, Klebsiella, Rhodobacter, Flavobacterium, Acetobacter, Gluconobacter, Rhizobium, Agrobacterium, Salmonella and Pseudomonads, which encode L-arabinose isomerase, L-ribulokinase, and L-ribulose phosphate 4-epimerase, transaldolase and transketolase, and/or Zymomonas mobilis containing exogenous genes from a microorganism selected from the group consisting E. coli, Xanthomonas, Klebsiella, Rhodobacter, Flavobacterium, Acetobacter, Gluconobacter, Rhizobium, Agrobacterium, Salmonella and Pseudomonads, which encode xylose isomerase and xylolukinase, transaldolase and transketolase, wherein the microorganism is capable of growing on xylose as a sole carbon source and fermenting said xylose to ethanol at about 88% of theoretical yield. ^ST CA\WINWORD10NAMPJCWODEL6TEO582.DOC L ni
19. The process of claim 18, further comprising the addition of hydrolytic enzymes such as cellulase enzyme complex and the mixed sugar feedstock also contains cellulose.
The process of claim 13 or 14, wherein the genes encoding said xylose isomerase and xylulokinase are expressed under the control the Z. mobilis glyceraldehyde-3-phosphate dehydrogenase promoter and said transaldolase and transketolase are expressed under the control of the Z.mobilis enolase promoter, whereby said genes are expressed in said microorganism to confer upon said microorganism an ability to ferment xylose directly to ethanol.
21. A microorganism according to claim 1 substantially as hereinbefore described with reference to any of the examples.
22. A vector according to claim 9 substantially as herein described with *reference to any of the examples.
23. A process according to claim 13 substantially as hereinbefore described oo 15 with reference to any of the examples.
"24. A process according to claim 18 substantially as hereinbefore described with reference to any of the examples. 00 DATED: 10 June, 1998 6 PHILLIPS ORMONDE FITZPATRICK Attorneys for: MIDWEST RESEARCH INSTITUTE c:WINWORDFIONA\PJCNODELETE50582.DOC ABSTRACT OF THE DISCLOSURE The invention relates to microorganisms which normally do not ferment pentose sugar and which are genetically altered to ferment pentose sugar to produce ethanol, and fermentation processes utilizing the same. Examples include Zymomonas mobilis which has been transformed with combinations ofE. coli genes for xylose isomerase, xylulokinase, transaldolase, transketolase, L-arabinose isomerase, L-ribulokinase, and L- ribulose 5-phosphate 4-epimerase. Expression of the added genes are under the control of Zymomonas mobilis promoters. These newly created microorganisms are useful for fermenting pentoses and glucose, produced by hydrolysis of hemicellulose and cellulose, to produce ethanol. t 'I t I f I j r:4 1 4 44 6i4. 4^
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/421,996 US5726053A (en) | 1994-04-15 | 1995-04-14 | Recombinant Zymomonas for pentose fermentation |
| US421996 | 1995-04-14 | ||
| US08/422,424 US5712133A (en) | 1994-04-15 | 1995-04-14 | Pentose fermentation by recombinant zymomonas |
| US422424 | 1995-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5058296A AU5058296A (en) | 1996-10-24 |
| AU698662B2 true AU698662B2 (en) | 1998-11-05 |
Family
ID=27025447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50582/96A Expired AU698662B2 (en) | 1995-04-14 | 1996-04-11 | Pentose fermentation by recombinant zymomonas |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR100455096B1 (en) |
| AU (1) | AU698662B2 (en) |
| CA (1) | CA2173793C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU774414B2 (en) * | 1997-05-06 | 2004-06-24 | Midwest Research Institute | Single (zymomonas mobilis) strain for xylose and arabinose fermentation |
-
1996
- 1996-04-10 CA CA2173793A patent/CA2173793C/en not_active Expired - Lifetime
- 1996-04-11 AU AU50582/96A patent/AU698662B2/en not_active Expired
- 1996-04-13 KR KR1019960011100A patent/KR100455096B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100455096B1 (en) | 2005-01-13 |
| AU5058296A (en) | 1996-10-24 |
| KR960037834A (en) | 1996-11-19 |
| CA2173793C (en) | 2011-01-11 |
| CA2173793A1 (en) | 1996-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5712133A (en) | Pentose fermentation by recombinant zymomonas | |
| US5514583A (en) | Recombinant zymomonas for pentose fermentation | |
| EP0737742A2 (en) | Pentose fermentation by recombinant zymomonas | |
| US5843760A (en) | Single zymomonas mobilis strain for xylose and arabinose fermentation | |
| Deanda et al. | Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering | |
| US6566107B1 (en) | Recombinant Zymomonas mobilis with improved xylose utilization | |
| Chandrakant et al. | Simultaneous bioconversion of cellulose and hemicellulose to ethanol | |
| Gunasekaran et al. | Ethanol fermentation technology–Zymomonas mobilis | |
| Krishnan et al. | Fermentation kinetics of ethanol production from glucose and xylose by recombinant Saccharomyces 1400 (pLNH33) | |
| Levin et al. | Challenges for biohydrogen production via direct lignocellulose fermentation | |
| CN105199976B (en) | Recombinant saccharomyces cerevisiae strain for co-fermenting glucose and xylose and application thereof | |
| CA2761968C (en) | Zymomonas with improved arabinose utilization containing a heterologous gene encoding an arabinose-proton symporter | |
| Eiteman et al. | A substrate‐selective co‐fermentation strategy with Escherichia coli produces lactate by simultaneously consuming xylose and glucose | |
| EP0973915A1 (en) | Recombinant microorganisms capable of fermenting cellobiose | |
| CN101781634B (en) | Recombinant zymomonas mobilis capable of producing ethanol by using xylose and fermentation method thereof | |
| AU2011334846A1 (en) | Method for preparing an industrial yeast, industrial yeast and use in the production of ethanol from at least one pentose | |
| US5726053A (en) | Recombinant Zymomonas for pentose fermentation | |
| US11091782B2 (en) | Engineered zymomonas for the production of 2,3-butanediol | |
| CN116925987A (en) | High-yield stress-resistant strain strengthened by teichoic acid synthesis, construction method thereof and polyol fermentation application | |
| AU698662B2 (en) | Pentose fermentation by recombinant zymomonas | |
| CN114957413A (en) | Escherichia coli global regulatory factor cyclic adenosine monophosphate receptor protein mutant, genetic engineering bacteria and application | |
| JPWO2009081941A1 (en) | Bioethanol parallel fermentation from woody and herbaceous biomass saccharified liquors | |
| Liu et al. | gTME for construction of recombinant yeast co-fermenting xylose and glucose | |
| CN114874961B (en) | Recombinant zymomonas mobilis for synthesizing acetoin by using acetaldehyde, and construction method and application thereof | |
| JP2005261421A (en) | Pentose fermentative transformed microorganism of genus zymobacter |